PATENT CLAIM ANALYSIS

Application Number: 15770162
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["544", "359000"]

Abstract:
The invention provides a series of substituted aryl pyrimidine compounds and the use of these compounds as therapeutics to treat or prevent neurodegenerative disorders, including Parkinson's disease. Compounds of the invention are also able to treat the symptoms of such diseases and therefore represent a new treatment modality for ameliorating chronic and acute conditions. The compounds of the invention are capable of selectively potentiating the activity of the Nurr1:RXRα heterodimer, and are able to treat diseases or conditions associated with aberrant Nurr1:RXRα function. The invention further provides methods for treating neurodegenerative disorders by administration of Nurr1:RXRα activating agents.

Claim (Index 51):
The compound of  claim 49 , wherein n is 0 or 1, and wherein p is 0 or 1.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 91.0
- Lexical Diversity: 1.73438
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13770706', '14339772', '13770676', '14886332', '13594223']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7816890020390999
- 35 USC 102 Novelty (BERT): 0.5248116797492112
- Combined Prediction Score: 0.756001269810111
- Mean Citation Score: 320.490044
- Max Citation Score: 323.06412
- Similarity Product: 178.69113264588117

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test